Effects of environment on drinking behaviors in people with alcohol use disorder
Official title: Environment and Alcohol: A Pilot Study
Run by National Institutes of Health Clinical Center (CC) · NCT06860607 · Data updated 2026-11-12
This study is testing how different activities and surroundings can help people with alcohol use disorder drink less and feel better.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 21 Years to 100 Years |
| Sex | All |
| Enrollment | 44 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | November 15, 2026 |
| Main results expected | March 1, 2027 |
| Study ends | March 1, 2028 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT06860607 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 21 and older who have a diagnosis of alcohol use disorder and meet specific drinking criteria.
✕Probably not a fit
Patients who do not have alcohol use disorder or those who are not willing to engage with the study's mobile app may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to evaluate how different activities and environments influence drinking behaviors and mental health in individuals with alcohol use disorder (AUD). Participants aged 21 and older will undergo a series of assessments, including physical exams, blood and urine tests, and psychological evaluations. They will also use an app to provide real-time feedback on their alcohol consumption and related behaviors. The study will focus on the impact of environmental enrichment on reducing alcohol consumption and cravings.
Why it matters
Potential benefit: If successful, this study could lead to new therapeutic strategies that incorporate environmental changes to help individuals with alcohol use disorder reduce their drinking.
How similar studies have gone: While the approach of using environmental enrichment is innovative, similar studies have shown promise in behavioral interventions for alcohol use disorder.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:
To meet eligibility for this study, participants must meet all the following criteria:
1. At least 21 years old
2. Owns a cellular device ("smart phone") and is willing to download the EMA application and use it to answer the study questionnaires
3. Diagnosis of alcohol use disorder (minimum of 2 DSM-5 criteria on a valid diagnostic tool, e.g., Mini-International Neuropsychiatric Interview (MINI) or the Structured Clinical Interview for DSM Disorders (SCID))
4. Self-reported drinking, according to alcohol Timeline Follow-Back (TLFB), of \> 7 drinks per week for females or \> 14 drinks per week for males, on average, during the 28-day period prior to screening + at least four days with \> 3 drinks for females or \> 4 drinks for males during the 28-day period prior to screening
5. Most recent Clinical Institute Withdrawal Assessment for Alcohol - revised (CIWA-Ar) score \< 10
6. If a female of childbearing potential: not pregnant or breastfeeding, no intention to become pregnant during the study duration, and agrees to use a highly effective contraception method to prevent pregnancy for the entire study duration. Highly effective contraception methods will be determined by the MAI or designee.
EXCLUSION CRITERIA:
Any individual who meets any of the following criteria will be excluded from this study:
1. Current use of FDA-approved pharmacotherapy for AUD (or of a medication intended as an off-label use to treat AUD as determined by the MAI), or currently seeking treatment for AUD
2. Medical and/or mental health conditions that are clinically unstable and would therefore compromise the safety and/or scientific integrity of the study, as determined by the MAI or study team respectively.
3. Known history of clinically significant cybersickness.
4. Any other reason or clinical condition that the Investigators judge would interfere with study participation and/or be unsafe for a participant
5. Unable to speak, read, write, and understand English
Justification: Many of the assessments have only been validated in English, and therefore, a non-English translation would jeopardize the scientific integrity of the study.
Where it's running
-
National Institute on Drug Abuse
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Lorenzo Leggio, M.D. — National Institute on Drug Abuse (NIDA)
- Study coordinator: Ryan E Tyler
- Email: ryan.tyler@nih.gov
- Phone: (240) 789-0347
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Thiamine to reduce brain injury in adults with alcohol use disorder
This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.
-
Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit
This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.
-
Path180: a computer-based skills program to help teens reduce alcohol use
This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Psilocybin in Alcohol Use Disorder with Depression (Relapse Prevention)
This study tests whether higher-dose psilocybin-assisted psychotherapy helps prevent relapse in adults with severe alcohol use disorder and depressive symptoms after detox.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.